Tacrolimus for Remission Induction and Maintenance Therapy in Patients with Ulcerative Colitis: A Retrospective Evaluation Study [PDF]
Ayumi Ito+4 more
openalex +1 more source
Objective To compare clinical and radiological outcomes among relapsing multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT), alemtuzumab (ATZ), and ocrelizumab (OCR). Methods From a London (UK) hospital‐based observational cohort, modeled data were obtained from 621 relapsing–remitting multiple sclerosis ...
Paolo Antonio Muraro+16 more
wiley +1 more source
Administration of amifostine in the stage of remission induction can benefit the patients with hematological malignancy in autologous stem cell transplantation: a retrospective study. [PDF]
Wu M, Wu K, Chen P, Li P, Xie Y.
europepmc +1 more source
P624. Effectiveness and safety of vedolizumab for the induction of remission in inflammatory bowel disease [PDF]
openalex +1 more source
Objective Neuroimaging is routinely utilized to identify new inflammatory activity in multiple sclerosis (MS). A large language model to classify narrative magnetic resonance imaging reports in the electronic health record (EHR) as discrete data could provide significant benefits for MS research. The objectives of the current study were to develop such
Shane Poole+14 more
wiley +1 more source
Genomics of primary chemoresistance and remission induction failure in pediatric and adult acute myeloid leukemia [PDF]
Fiona C. Brown+19 more
openalex +1 more source
Functional Synovium‐Based 3D Models in the Context of Human Disease and Inflammation
The synovium is key to joint function but is often affected by diseases like rheumatoid arthritis. Finding better treatments is challenging because current lab models do not fully mimic real tissues. New 3D technologies, like bioprinting, offer better methods to study these diseases, improve drug testing, and develop personalized treatments, bringing ...
Amelia Heslington+3 more
wiley +1 more source
Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia. [PDF]
Proc P+4 more
europepmc +1 more source